针刺配合肠炎散保留灌肠治疗肛窦炎临床研究

目的观察肛窦炎应用针刺配合肠炎散保留灌肠治疗的效果。方法选取2017年10月-2018年10月就诊的72例肛窦炎患者,采用随机数字表法分为观察组(n=36)与对照组(n=36)。对照组给予肠炎散保留灌肠治疗,观察组为针刺配合肠炎散保留灌肠治疗,比较2组症状、疗效及安全性。结果观察组症状(放射痛、指诊症状及镜检症状)少于对照组,总有效率高于对照组,差异有统计学意义(P<0.05);2组安全性相比,差异无统计学意义(P>0.05)。结论针对肛窦炎患者,予以针刺配合肠炎散保留灌肠治疗效果确切,可减少临床症状,加快疾病转归,且治疗安全性较好。     

Mucinous adenocarcinoma arising from chronic perianal fistula

Perianal mucinous adenocarcinoma is a rare tumour which may be associated with long‐standing chronic perianal sepsis. Early diagnosis is challenging and is based on a high index of clinical suspicion and specific histological features. Definitive treatment is surgical, in the form of an abdomino‐perineal resection. We hereby describe a case of a perianal mucinous adenocarcinoma arising from long‐standing recurrent perianal fistula and complement this with a brief review of the literature pertaining in particular to the management of this condition.     

一期切开挂线术治疗肛周脓肿305例

采用一期切开挂线术治疗肛周脓肿３０５例，全瓿期治愈，无发生肛瘘及并发症者。作者认为手术成功的关键是正确处理内口及原发灶，良好通畅的切口引流以及合理的术后处理，对提高疗效，防止复发有重要意义。     

膝胸卧位红光照射联合肛提运动对产后痔急性发作的疗效

目的 探讨膝胸卧位红光照射联合肛提运动对产后痔急性发作的改善效果.方法 将68例经阴道分娩并发产后痔急性发作的产妇按入院时间分为对照组36例、观察组32例.两组产妇产后给予相同的产褥期知识宣教、母婴护理指导等常规护理措施,在此基础上,对照组采用屈膝侧卧位配合红光照射,观察组给予膝胸卧位红光照射联合肛提运动.观察两组产后24 h和产后5d痔疼痛程度、肛周水肿程度、治疗效果、治疗过程舒适度.结果 干预后两组疼痛评分、肛周水肿程度、治疗效果比较,差异有统计学意义(均P＜0.01);两组治疗过程舒适程度差异无统计学意义(P＞0.05).结论 产后痔急性发作的产妇应用膝胸卧位红光照射配合肛提运动能有效减轻产妇疼痛及肛周水肿程度,治疗效果较好.     

肛周坏死性筋膜炎术后热毒炽盛期应用解毒消痈饮的疗效观察

[目的] 探讨解毒消痈饮治疗肛周坏死性筋膜炎术后热毒炽盛期的临床效果。[方法] 将60例肛周坏死性筋膜炎患者随机分为对照组和观察组,各30例。对照组采用术后对症支持的常规治疗+痛痒消洗剂坐浴,观察组在对照组的基础上,术后口服解毒消痈饮治疗。[结果] 观察组治疗后第3、7、14天视觉模拟评分量表（VAS）评分均低于对照组,差异具有统计学意义（P<0.05）;两组治疗14 d后白细胞（WBC）、C-反应蛋白（CRP）、白细胞介素-6（IL-6）较治疗前显著减低,且观察组明显低于对照组（P<0.05）,而血红蛋白（Hb）较治疗前明显升高,且观察组优于对照组（P<0.05）;两组治疗14 d后坏死性筋膜炎实验室风险指数评分（LRINEC）、Fournier坏疽严重程度指数（FGSI）均较治疗前显著减低,且观察组明显低于对照组（P<0.05）;观察组治疗后第7、14天创面渗液和创面水肿情况评分均低于对照组,差异具有统计学意义（P<0.05）;观察组创面愈合时间较对照组短（P<0.05）;观察组的总有效率优于对照组（P<0.05）。[结论] 肛周坏死性筋膜炎术后热毒炽盛期应用解毒消痈饮疗效确切,能够有效缓解术后疼痛,降低炎症反应,提高血红蛋白含量,有利于评估患者术后病情及预后,减轻术后创面渗液和创面水肿,加速创面愈合。     

急性肛周脓肿手术方法的改进

目的:探讨、研究急性肛周脓肿一期根治新术式.方法:回顾分析 1996～ 2004年 123例急性肛周脓肿一期根治术式 改进后病人的临床资料.结果:所有病人均一次性治愈,无术后复发肛瘘及遗留肛门失禁.结论:采用该术式治疗急 性肛周脓肿,具有治愈率高、病人痛苦小、手术恢复快、费用低、并发症少等优点.     

帕瑞昔布钠和曲马多在肛周脓肿术中超前镇痛的效果比较

肛周脓肿是肛肠外科常见病和多发病，手术是主要治疗手段，其手术创面通常较大，间隙较深，术后疼痛常较剧烈，因此短期内常需反复依靠镇痛药缓解疼痛。超前镇痛是指在伤害性刺激作用于机体之前采取一定的措施，防治神经中枢敏化，减少或消除伤害引起的疼痛[1]。目前已越来越多地应用于临床，并显示出较好的术后镇痛效果。本研究对帕瑞昔布钠和盐酸曲马多在肛周脓肿术中超前镇痛的临床疗效和不良反应进行比较，为临床实际问题提供解决方案。     

微创挂线术治疗直肠肛周脓肿的效果

〔摘 要〕 目的：评价直肠肛周脓肿患者运用微创挂线术治疗的效果。方法：选取 2019 年 1 月至 2020 年 1 月期间 安阳市中医院接收治疗的直肠肛周脓肿患者 50 例为研究对象，根据不同治疗方式分为对照组和观察组，各 25 例。对 照组接受一期根治术治疗，观察组展开微创挂线术治疗，术后比较两组患者手术指标、临床疗效、疼痛程度数字评估 量表（NRS）评分及日常生活能力评定量表（ADL）评分等。结果：观察组患者的手术时长、住院天数、手术出血量、 创面愈合时间等指标均优于对照组，差异具有统计学意义（P ＜ 0.05）。在临床疗效方面，观察组患者的总有效率明 显更高于对照组，差异具有统计学意义（P ＜ 0.05）。术后，两组患者的 NRS 评分均下降，ADL 评分均上升，且观 察组 NRS 评分低于对照组，ADL 评分高于对照组，差异均具有统计学意义（P ＜ 0.05）。结论：直肠肛周脓肿患者 运用微创挂线术治疗，相对于一期根治术可以缩短治疗时间和患者康复时间，且能更有效地提高患者的日常生活能力， 降低术后疼痛。     

Efficacy of combined anti-TNF-alpha and surgical therapy in perianal and enterocutaneous fistulizing Crohn’s disease – clinical observations from a tertiary Eastern European center

Abstract

Background and aims. Recently, anti-TNF-alpha therapy has increasingly been used in the treatment of perianal Crohn’s disease (PCD), but there is only limited data regarding its short- and long-term efficacy. Material and methods. The medical records of 68 patients treated with anti-TNF-alpha for PCD were assessed retrospectively. Rate of complex fistulas was 75%. Every patient received induction therapy, but in 20 cases the treatment was discontinued before week 52 due to funding regulations, an allergic reaction, or compliance problems. On week 12, the luminal activity decreased in more than 80% of the cases and the complete remission (CR) rate was about 60%; by the end of the first year, this ratio did not change substantially. Complete fistula closure was achieved in 26 cases (38.3%) and 53 patients (51.5%) showed a partial response during the 1-year period. Regarding both perianal and luminal activities, CR rate was achieved in 23 cases (33.8%). However, after the biological therapy was discontinued, recurrence of fistulas could be detected in every second patient. Additional surgical intervention was performed in 45% of patients during the 1-year period (seton drainage of fistulas and abscess drainage). Conclusion. The anti-TNF-alpha therapy combined with surgery is an effective treatment of PCD. Approximately every third patient revealed complete fistula closure, while half of the other cases showed a partial response. Due to the high rate of fistula recurrence after stopping the biological therapy, more than 1 year of anti-TNF-α treatment may be beneficial.